Company profile

Curacle

Vascular/immunology biotech

365270 · KOSDAQ · South Korea

Public Market Listing

365270KOSDAQ

KOSDAQ primary exchange listing

Live quotes, historical charts, and market capitalization for Curacle are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
CU01-1001
Phase 2
Nrf2 / TGF-betaSmall molecule
Chronic Kidney Disease
CU104
Phase 2
Endothelial barrier functionSmall molecule
Inflammatory Bowel Disease
Ulcerative Colitis

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.